AMARANTUS BIOSCIENCE HOLDINGS INC has a total of 14 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, computer technology and biotechnology are GEORGIA HEALTH SCIENCES UNIVERSITY RES INST INC, AROG PHARMACEUTICALS INC and VASCULAR BIOSCIENCES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Computer technology | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Bioinformatics | |
#5 | Measuring microorganism processes | |
#6 | Peptides | |
#7 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Lowe David A | 7 |
#2 | Keywood Charlotte | 4 |
#3 | Commissiong Gerald | 3 |
#4 | Commissiong John | 3 |
#5 | Wilks Tom | 2 |
#6 | Commissiong John W | 2 |
#7 | Urfer Roman | 2 |
Publication | Filing date | Title |
---|---|---|
US2019060402A1 | Method of enhancing dopaminergic neuronal cell growth or survival with manf | |
US2018051336A1 | Methods for diagnosing multiple sclerosis using vh4 antibody genes | |
US2018263975A1 | Methods Of Treating Motor And Movement Disorders And Side Effects Thereof Associated with Parkinson's Disease Treatments | |
WO2016057579A1 | Methods and compositions for treating retinal disorders | |
EP3011336A1 | Methods, systems, and composition related to neural disorders | |
WO2014066686A1 | Brain targets for neurotrophic factors to treat neurodegenerative disease |